12:00 AM
 | 
Jan 10, 2000
 |  BC Week In Review  |  Company News  |  Deals

Cambridge Drug Discovery Ltd., Cambridge Genetics, Oxford Molecular deal

Cambridge Genetics acquired Cambridge Drug in a stock transaction. Cambridge Genetics also bought OMG's 19.99 percent stake in Cambridge Drug for £650,000...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >